The Senate Committee on Health, Education, Labor and Pensions held a hearing on Tuesday, to discuss Novo Nordisk lowering prices for weight-loss drugs.
held a hearing on Tuesday to discuss popular drug maker Novo Nordisk lowering prices for blockbuster weight-loss drugs Ozempic and Wegovy .
C. Michael White is a professor in the School of Pharmacy at the University of Connecticut. He said some"They're going to cost you a little over $1,000 a month," said White. "It is clear patients too often struggle to navigate the complex U.S. healthcare system," said Jorgensen.
Weight-Loss Drugs Ozempic Wegovy Drug Prices Pharmacy Benefits Managers Healthcare System Senate Committee
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk CEO Defends Ozempic Price In Senate TestimonyTy Roush is a New York City-based breaking news reporter who frequently covers Russia’s invasion of Ukraine, the automotive industry and sports money. He joined Forbes in 2022 and has covered Exxon acquiring Pioneer for nearly $60 billion, a mysterious respiratory illness affecting dogs across the U.S.
Read more »
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugsSen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Read more »
Novo Nordisk CEO testifies at Senate hearing over high weight loss drug pricesSen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Read more »
Novo Nordisk CEO Faces Tough Questions on Drug PricesThe chief executive of Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face scrutiny from Senator Bernie Sanders and the Senate Finance Committee on Tuesday regarding the high costs of the company’s popular weight-loss drugs, Ozempic and Wegovy.
Read more »
Novo Nordisk CEO Claims High Drug Prices Due to US Healthcare SystemNovo Nordisk CEO Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the high cost of the company's weight-loss drugs, Ozempic and Wegovy. Jørgensen claimed the high prices were due to complications of the U.S. healthcare system.
Read more »
Novo Nordisk CEO to Face Senate Grilling Over High Drug PricesThe CEO of Novo Nordisk, Lars Fruergaard Jørgensen, will testify before the Senate Health, Education, Labor and Pensions Committee on Tuesday regarding the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic. Sen. Bernie Sanders, who chairs the committee, alleges that Novo Nordisk charges significantly higher prices for its drugs in the US compared to other countries.
Read more »